Navigation Links
Hospira's Precedex(R) Phase IV Study Published in the Journal of the American Medical Association
Date:2/2/2009

cent in Precedex-treated patients vs. 76.6 percent in midazolam-treated patients. Median time to removal from mechanical ventilation was 3.7 days in the Precedex-treated patients vs. 5.6 days in the midazolam-treated patients, a difference of 44 hours. Precedex-treated patients were more likely to develop bradycardia, or slow heartbeat, but had a lower likelihood of tachycardia (fast heartbeat) or hypertension that required treatment.

The study design used in this phase IV trial incorporated new standard elements of sedation practice, including a light-to-moderate sedation target, delirium assessment, and study drug titration or interruption every four hours and as part of a daily arousal assessment.

"This multicenter study is one of the largest to compare two different sedatives for use in the ICU in a randomized and blinded design," said Richard R. Riker, M.D., director of critical care research, Division Pulmonary and Critical Care Medicine, Maine Medical Center. "Patients who received Precedex were extubated sooner and had a lower prevalence of delirium. I expect that patients requiring long-term sedation, their families and healthcare providers will welcome the results of this trial."

There are more than 5 million patients treated annually in the ICU(1). In 2003, there were nearly 300,000 prolonged mechanical ventilation discharges in the United States at an annual aggregated hospital cost of more than $16 billion. At a cost of more than $1,500 per patient-day(2), mechanical ventilation represents a significant contribution to overall expenses in the intensive care setting and drives a disproportionate share of resource utilization.

Providing sedation for patient safety and comfort is an integral component of bedside care for nearly every patient in the ICU, and practice guidelines for sedation in the ICU have identified the need for well-designed randomized trials comparing the eff
'/>"/>

SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Ovation further advances development pipeline with new phase III epilepsy study
2. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
3. Mannatech Launches Phase One of New Sales and Training Tools
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Manic phase of bipolar disorder benefits from breast cancer medication
6. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
7. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
8. Alexza to Initiate the First Phase 3 Trial for AZ-004 (Staccato(R) Loxapine) in Late Q1 2008
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. MetLife Foundation Begins New Phase of Award-Winning Parenting Skills Campaign in Collaboration with the Partnership for a Drug-Free America(R)
11. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... ... Author Francesca Camp wasn’t always a steadfast supporter of plastic surgery. But just ... of the practice; a terrible car accident years ago left her injured and in need ... It ? (And What if I Do?): Answers to All Your Questions about Plastic Surgery” ...
(Date:7/1/2015)... ... 2015 , ... After conducting a nationwide executive search ... Center in Oceanside, Calif., has hired Cheryle Bernard-Shaw as chief compliance officer. ... efforts and growing a focus on risk management, Bernard-Shaw will assume her new ...
(Date:7/1/2015)... ... July 01, 2015 , ... Incentivizing the use of generic drugs ... discounts as much as 80% or 90% off the prices for the brand-name products. ... act to mitigate the financial impact of these high-cost generic drugs. The July issue ...
(Date:7/1/2015)... Beach, CA (PRWEB) , ... July 01, 2015 ... ... has returned to the Northbound team as Director of Referral Relations. , ... programs, including Northbound’s Collegebound, where she designed and implemented unique academic curriculum for ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Thule Atmos X4 offers ... tested to ensure it lived up to Thule’s rigorous standards. Due to its Bi-ComponentArmor ... quality Thule owners have come to expect. , The Thule Atmos X4 ...
Breaking Medicine News(10 mins):Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 2Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 3Health News:Northbound Treatment Services Welcomes Emily Orrick as Director of Referral Relations 2
... A new study presented at the Annual Congress for Dermatological ... supplement marketed by Paris-based IsoCell Nutra, significantly increased the levels ... claim that SOD has a different mode of action to ... first discovered in 1968, it is the first antioxidant mobilized ...
... reduce the bulging girth of the abdomen in middle aged and ... who have conducted a study showed that regular practice of yoga ... years can lead to arrest of weight gain in obese people ... collected from 15,500 men and women in the age group of ...
... Asia. Foreigners often come to this side of the content ... in their own countries. ,More and more Globetrotters are ... during the monsoons. Why you may ask? Well it’s believed ... therapy is in the rainy months of June, July and ...
... in Pakistan has shown that handwashing ,with soap prevents ... lower respiratory infections. ,These two infections have ... under 5 years of age ,every year in the ... socio economic groups. ,In the current study done in ...
... after consumption of abortion pill cause concern to women consuming ... physicians regarding the latest reports of death of 5 women ... also called as Mifeprex or Mifepristone. Mifeprex is an approved ... The drug was introduced in the market five years ago. ...
... patients have died amid a strike by junior doctors at ... third day Saturday crippling medical services. ,Two patients died ... patients, mostly poor people who have come for treatment from ... real victims of the strike because there is no doctor ...
Cached Medicine News:Health News:New Supplement Found To Be Effective Against Sunburn 2Health News:Ayurvedic Therapies Cashing In On Medical Tourism 2Health News:Fresh warnings to doctors regarding abortion pill 2
(Date:7/1/2015)... FRANCISCO , July 1, 2015 ... market) is expected to reach USD 49,119.2 million by ... Research, Inc. Monitoring services is expected to remain the ... of USD 1,227.5 million in 2012, and an estimated ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , Browse ...
(Date:6/30/2015)... Scotland , July 1, 2015 ... joins Nu C ana team   ... ProTide technology to develop and commercialise a portfolio of ... Chris McGuigan as Chief Scientific Officer. ... ProTide technology. He is currently Professor of Medicinal Chemistry ...
(Date:6/30/2015)... , June 30, 2015 Velos, Inc., the ... continues to grow and add customers who receive Clinical ... the 62 CTSAs awarded by the National Institutes of ... management. This is among the largest such market shares ... in the CTSA community keeps growing as a result ...
Breaking Medicine Technology:mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 2mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 5Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3Velos continues adding CTSA customers - 40% now use Velos products 2
... 2011 The Mobile Dog Heart Health Tour is heading ... health examinations at Dreher Dog Park. From 1 to 5 ... on-site heart screenings in a soundproof medical unit, as well ... (Photo:   http://photos.prnewswire.com/prnh/20110127/CG37759 ) Since early 2009, veterinarians ...
... Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUSD) ("Lotus" or ... of medicine and drugs in the People,s Republic of ... investor interest, the Company has obtained land price guidance ... wishes to provide additional details regarding its 2008 purchase ...
Cached Medicine Technology:Vets to Provide Free Dog Heart Checks in West Palm Beach 2Vets to Provide Free Dog Heart Checks in West Palm Beach 3Lotus Pharmaceuticals Provides Inner Mongolia Land Price Guidance from Cha You Qian Qi Government 2
... Level 1 enables hospitals ... patient monitors to a ... Our temperature monitoring disposale ... are superior in their ...
... The pause of a heartbeat. The bodys ... rhythmic breathing. These vital signs are yours ... DeRoyals line of Temperature Monitoring products helps ... information needed to provide the most comfortable ...
... a heartbeat. The bodys warmth beneath drapes. ... vital signs are yours to guard, measure, ... Temperature Monitoring products helps you do your ... provide the most comfortable and precise management ...
... The bodys warmth beneath drapes. The life-giving ... are yours to guard, measure, stabilize and ... products helps you do your job, giving ... most comfortable and precise management of your ...
Medicine Products: